TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

SUNSHINE LAKE

Infectious DiseaseOncologyRespiratory
Pharma

SUNSHINE LAKE is a pharmaceutical company focused on Infectious Disease, Oncology, Respiratory.

-
Since
2
Drugs
-
Trials
3
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

APIXABAN 2025-02-27
APIXABAN 2025-02-14
APIXABAN 2024-12-17
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 45%
0 drugs Phase 3: 1 Phase 2: 5 Phase 1: 14
Oncology 29%
0 drugs Phase 3: 2 Phase 1: 10
Respiratory 18%
0 drugs Phase 3: 1 Phase 2: 1 Phase 1: 5
Metabolic 6%
0 drugs Phase 1: 4
Neurology 2%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

GSK big-pharma
Infectious Disease, Respiratory, Oncology, Neurology
Sanofi big-pharma
Metabolic, Oncology, Infectious Disease, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Neurology, Oncology, Respiratory
Merck big-pharma
Oncology, Infectious Disease, Metabolic
Novo Nordisk big-pharma
Metabolic, Oncology, Infectious Disease, Neurology